FJ

Frank L. Meyskens, Jr.

University of California: 6 patents #1,311 of 18,278Top 8%
UA University Of Arizona: 4 patents #107 of 1,318Top 9%
Northwestern University: 2 patents #821 of 3,846Top 25%
CU Chapman University: 1 patents #8 of 25Top 35%
📍 Irvine, CA: #1,114 of 6,241 inventorsTop 20%
🗺 California: #66,801 of 386,348 inventorsTop 20%
Overall (All Time): #548,880 of 4,157,543Top 15%
9
Patents All Time

Issued Patents All Time

Showing 1–9 of 9 patents

Patent #TitleCo-InventorsDate
12128015 APE/REF1 inhibitors for the treatment of cancer Sun Yang, Keykavous Parang, Richard Chamberlin 2024-10-29
9980924 Topical pterostilbene compositions for use in treating UV-induced loss of barrier function in skin Ryan Dellinger 2018-05-29
9937141 Carcinoma diagnosis and treatment, based on ODC1 genotype Eugene Gerner, Jason A. Zell, Christine E. McLaren, Hoda Anton-Culver, Particia A. THOMPSON 2018-04-10
9121852 Carcinoma diagnosis and treatment, based on ODC1 genotype Eugene Gerner, Jason A. Zell, Christine E. McLaren, Hoda Anton-Culver, Patricia A. Thompson 2015-09-01
9090589 Specific nNOS inhibitors for the therapy and prevention of human melanoma Richard B. Silverman, Sun Yang, Haitao Ji, Fengtian Xue, Thomas L. Poulos 2015-07-28
8642282 Inhibitors of nitric oxide synthase for treatment of melanoma Richard B. Silverman, Sun Yang, Haitao Ji, Fengtian Xue, Thomas L. Poulos 2014-02-04
8329636 Carcinoma diagnosis and treatment, based on ODC1 genotype Eugene Gerner, Jason A. Zell, Christine E. McLaren, Hoda Anton-Culver, Patricia A. Thompson 2012-12-11
6428816 Carotenoid agent for inhibiting the conversion of epithelial cells to tumors Lance Elliot Schlipalius, Julie A. Buckmeier 2002-08-06
6258845 DFMO and sulindac combination in cancer chemoprevention Eugene Gerner 2001-07-10